Page last updated: 2024-11-13

d-argininamide, d-phenylalanyl-d-phenylalanyl-d-norleucyl-n-(4-pyridinylmethyl)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID25030387
SCHEMBL ID4451321
MeSH IDM0577432

Synonyms (17)

Synonym
cr665
cr-665
fe200665
fe-200665
unii-3bx9ug06gg
228546-92-7
3bx9ug06gg ,
cr 665
d-argininamide, d-phenylalanyl-d-phenylalanyl-d-norleucyl-n-(4-pyridinylmethyl)-
fe 200665
SCHEMBL4451321
DTXSID30177395
jnj-38488502
DB05155
Q5425398
HY-P3609
CS-0616401

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Plasma drug concentration data were used to generate pharmacokinetic models, which were then used to fit the VPTT data using NONMEM(®) VI to generate population pharmacokinetic/pharmacodynamic models."( A population pharmacokinetic and pharmacodynamic study of a peripheral κ-opioid receptor agonist CR665 and oxycodone.
Arendt-Nielsen, L; Drewes, AM; Kell, S; Kristensen, K; Olesen, AE; Staahl, C; Wong, GY, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
" Measurements were performed before dosing and at 30, 60, and 90 min after dosing."( Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.
Arendt-Nielsen, L; Drewes, AM; Kell, S; Menzaghi, F; Olesen, AE; Staahl, C; Wong, GY, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (40.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]